文献速递胃肠外科围术期管理与 ERAS

袖状胃切除术与可调节胃束带术在相似减重下的糖尿病结局比较

Comparing Diabetes Outcomes: Weight-independent Effects of Sleeve Gastrectomy Versus Matched Patients With Similar Weight Loss.
PubMed 文献 · Ann Surg · 2020-11-12

基于全州减重手术登记数据,988例术前诊断为糖尿病的患者接受腹腔镜袖状胃切除术(LSG)或腹腔镜可调节胃束带术(LAGB),按年龄、种族、性别、术前BMI和术后1年减重匹配。尽管两组1年BMI下降百分比相似(8.3% vs 8.1%,P=0.3811),LSG组口服降糖药、胰岛素、降压药和降脂药的停用率均显著高于LAGB组。结论提示LSG可能具有不依赖减重的代谢获益。

要点

  • LSG组口服降糖药停用率70.4%,显著高于LAGB组的46.0%(P<0.0001)。
  • LSG组胰岛素停用率51.7%,显著高于LAGB组的38.3%(P=0.0341)。
  • 两组1年BMI下降百分比相似(8.3% vs 8.1%,P=0.3811),提示LSG代谢获益不完全依赖减重。

核心结论

  • 在术前特征和术后减重相似的情况下,LSG患者停用糖尿病、高血压和降脂药物的比率显著高于LAGB患者。
  • 结果提示LSG可能对代谢疾病具有不依赖减重的效应,在糖尿病治疗中应考虑LSG而不必拘泥于减重效果。

研究设计与样本

  • 回顾性研究,使用全州减重手术登记数据,纳入988例术前诊断为糖尿病并接受LSG或LAGB的患者。
  • 按年龄、种族、性别、术前BMI和术后1年减重进行匹配,采用卡方检验比较药物停用情况。

主要发现

  • 患者平均年龄53.9岁,女性占75.5%,白人占89.3%,平均术前BMI为44.8 kg/m2。
  • 75.7%为非胰岛素依赖型糖尿病,24.3%为胰岛素依赖型糖尿病。
  • 两组1年BMI下降百分比相似(8.3% vs 8.1%,P=0.3811)。
  • LSG组口服降糖药停用率70.4% vs LAGB组46.0%(P<0.0001),胰岛素停用率51.7% vs 38.3%(P=0.0341)。
  • LSG组降压药停用率41.1% vs 26.0%(P<0.0001),降脂药停用率40.1% vs 27.8%(P=0.0016)。

临床怎么用

  • 对于合并糖尿病的减重手术患者,选择LSG可能比LAGB带来更高的糖尿病药物停用机会。
  • 在评估减重手术方式时,除减重效果外,应充分考虑LSG对代谢疾病的独立获益。

局限性

  • 研究为回顾性设计,可能存在未测量的混杂因素。
  • 数据来自单一全州登记系统,结果外推需谨慎。
  • 仅比较LSG与LAGB,未涉及其他常见术式如胃旁路术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine if sleeve gastrectomy has weight-independent benefits on diabetes outcomes. SUMMARY BACKGROUND DATA: Weight loss is recommended when treating conditions such as diabetes, hypertension, and hyperlipidemia. Bariatric surgery has been shown to improve or resolve metabolic conditions, but weight loss outcomes vary by procedure type. METHODS: Using data from a statewide bariatric surgery registry, a total of 988 patients with a preoperative diagnosis of diabetes who underwent either laparoscopic sleeve gastrectomy (LSG) or laparoscopic adjustable gastric banding (LAGB) were included in the study. The patients were matched based on age, race, sex, preoperative body mass index (BMi) and weight loss at 1 year after surgery. Chi-square comparisons were conducted for medication discontinuation for diabetes. Secondary outcome measures included discontinuation of medications for hypertension and hyperlipidemia. RESULTS: The mean age of patients was 53.9 years, 75.5% were female, 89.3% were White. Mean preoperative BMi was 44.8 kg/m2 and 75.7% had noninsulin dependent diabetes, whereas 24.3% had insulin dependent diabetes. Mean % BMi loss at 1 year is similar between the 2 groups (8.3% vs 8.1%, P = 0.3811). LSG patients had significantly higher rates of discontinuation of oral diabetes medication (70.4% vs 46.0%, P < 0.0001), insulin (51.7% vs 38.3%, P = 0.0341), anti-hypertensive (41.1% vs 26.0%, P < 0.0001), and cholesterol-lowering medications (40.1% vs 27.8%, P = 0.0016) when compared to LAGB patients. CONCLUSIONS: Despite similar preoperative characteristics and postoperative weight loss, LSG patients experienced significantly higher rates of medication discontinuation for diabetes, hypertension, and hyperlipidemia than LAGB. These results suggest that LSG may have weight-independent effects on metabolic disease and should be considered in the treatment of diabetes, regardless of perceived weight loss outcomes.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Yang P, Bonham AJ, Ghaferi AA, et al. Comparing Diabetes Outcomes: Weight-independent Effects of Sleeve Gastrectomy Versus Matched Patients With Similar Weight Loss. Ann Surg. 2020. PMID: 33201112. doi:10.1097/SLA.0000000000004298

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。